Developing Novel Therapeutics
to Meet Unmet Medical Needs
Our mission
Who we are and what we do intro.
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout
Mabwell Therapeutics, Inc. is a privately-held biotechnology company focusing on the discovery and development of antibody and protein-based drugs for patients with uncommon diseases.
How we got here / where we’re going
We are a wholly-owned subsidiary of Mabwell (Shanghai) Bioscience Co., Ltd . , a global integrated biopharmaceutical company primarily engaged in the discovery, development, manufacturing, and commercialization of biotherapeutics. Backed by a commercialization of biotherapeutics. Backed by a commercialization of biotherapeutics. Backed by a biopharmaceutical company in China. Its first product, an adalimumab biosimilar, is set to be marketed in 2021–and the company also has other therapeutic products in various clinical trial stages.
Looking for Partners and In-Licensing Opportunities
At Mabwell Therapeutics, we are always on the lookout for companies and investors who are interested in working with us to advance our own pipeline in the United States. We also seek in-licensing opportunities for novel therapeutics to initiate clinical testing and registration in China. Contact us. to get the conversation started.
We are striving to improve the lives of people with rare, debilitating diseases by leveraging the promise of science into novel antibody therapeutics.
Leadership Team
Mabwell therapeutics is led by an experienced team of scientists passionate in transforming basic science into novel therapies. With supports from a panel of scientific advisors reputable in the field, we are dedicated to bringing medicines to patients in need.
Xin Du, Ph.D.
Startup CEO
Xin Du has over 20 years of broad experience in the life sciences industry as a scientist. Prior to joining in pharmaceutical sector, Xin was Assistant…
Read more
Lei Huang, Ph.D.
Director, Antibody Engineering
Dr. Huang brings over 20 years of experience across several aspects of biopharmaceutical research, including drug development and critical reagent…
Read moreChunmei Zhao, Ph.D.
Associate Director, Biology
Dr. Zhao has broad experience and integrated scientific knowledge in cell biology, immunology and neuroscience. Prior to Mabwell…
Read moreMABWELL TEAM
Mabwell Advisors
Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tati feugiat nulla facilisis at vero.
First Last Name
Lorem Ipsum Dolore
Nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci suscipit lobortis…
Read moreFirst Last Name
Lorem Ipsum Dolore
Nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci suscipit lobortis…
Read more